Is a CT scan of the adrenal glands performed as an abdomen study or as an abdomen and pelvis study?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 6, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

CT of Adrenals: Abdomen Only

For dedicated adrenal gland imaging, a CT of the abdomen alone is sufficient, as the adrenal glands are located in the upper abdomen and do not require pelvic imaging for visualization.

Anatomic Rationale

The adrenal glands are retroperitoneal organs positioned at the superior poles of both kidneys in the upper abdomen, typically at the T12-L1 vertebral level 1. They are fully captured within standard abdominal CT protocols without extending the field of view to include the pelvis.

Evidence-Based Protocol Recommendations

Standard Adrenal Imaging

CT abdomen with IV contrast is the first-choice imaging modality for adrenal lesions 1. The most recent ACR Appropriateness Criteria (2025) and Endocrine Society guidelines consistently specify "CT abdomen" rather than "CT abdomen and pelvis" when imaging is specifically directed at the adrenal glands 2, 3.

For dedicated adrenal protocol CT, the standard approach includes 2:

  • Noncontrast phase (essential for measuring attenuation in Hounsfield Units)
  • Venous phase at 60-70 seconds post-contrast
  • Delayed phase at 15 minutes (for washout analysis)

The field of view extends from the diaphragm through the upper abdomen to adequately capture both adrenal glands.

When Pelvis IS Included

The pelvis should be added to create a "CT abdomen and pelvis" study only in specific clinical contexts where you're evaluating for:

  • Metastatic disease surveillance (e.g., lung cancer, renal cell carcinoma) where you need to assess multiple potential sites of spread 4, 5
  • Pheochromocytoma/paraganglioma workup where extra-adrenal paragangliomas can occur in the pelvis 1
  • Comprehensive oncologic staging where the primary concern extends beyond adrenal characterization

Important Distinction

In lung cancer surveillance, recent ASCO guidelines note that "CT of the chest including the adrenals" is sufficient—there is no evidence of added benefit for CT abdomen and pelvis over CT chest including adrenals 4. This reinforces that when adrenal evaluation is the goal, extending to the pelvis adds radiation exposure without diagnostic benefit.

Clinical Pitfalls to Avoid

  • Don't order "CT abdomen and pelvis" reflexively when the clinical question is specifically about adrenal characterization—this adds unnecessary radiation and cost
  • Do ensure noncontrast images are obtained if characterizing an adrenal lesion, as the <10 HU threshold on noncontrast CT has 98% specificity for benign adenoma 2, 3
  • Recognize that routine abdominal CT protocols (single venous phase) are NOT adequate for adrenal lesion characterization 2

In summary: Order "CT abdomen" for adrenal-specific imaging; reserve "CT abdomen and pelvis" for broader oncologic or systemic disease evaluation where pelvic pathology is a legitimate concern.

References

Guideline

pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline.

The Journal of clinical endocrinology and metabolism, 2014

Guideline

imaging of adrenal masses.

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologist, 2025

Guideline

acr appropriateness criteria on incidentally discovered adrenal mass.

Journal of the American College of Radiology, 2006

Guideline

acr appropriateness criteria® lung cancer-surveillance after therapy.

Journal of the American College of Radiology, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.